Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447590 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety Study of LAP-BAND Treatment for Obese Adolescents
A NA study, sponsored by Apollo Endosurgery.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT00447590: Completed NA study, sponsored by Apollo Endosurgery.
NCT00447590 is a NA study that has completed, run by Apollo Endosurgery. The registered enrollment target is 153 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00447590, a NA study, has completed, sponsored by Apollo Endosurgery.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the LAP-BAND system is safe and effective in morbidly obese adolescents.
Primary Outcome
Percent Excess Weight Loss was defined as Weight Loss divided by Excess Weight multiplied by 100. Excess Weight = baseline weight - ideal weight, where Ideal weight was determined using the 85th percentile on the Centers for Disease Control (CDC) Growth Charts for children and adolescents ages 2 to 20 years.
Interventions
- DEVICE LAP-BAND System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2007-03 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT00447590 record still lists
NCT00447590 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which LAP-BAND System is the first listed.
NCT00447590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00447590 about?
NCT00447590 is a clinical study titled "Effectiveness and Safety Study of LAP-BAND Treatment for Obese Adolescents". The purpose of this study is to determine whether the LAP-BAND system is safe and effective in morbidly obese adolescents.
What is the current status of trial NCT00447590?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2007-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00447590?
The interventions under investigation include: LAP-BAND System (DEVICE).
Who is sponsoring clinical trial NCT00447590?
This trial is sponsored by Apollo Endosurgery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00447590's enrollment target sits among peer trials
153 656th of 2000 higher than 1,343 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia